Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Attenuation of Airway and Cardiovascular Responses to Extubation in Chronic Smokers by Prior Treatment With Dexmedetomidine, Fentanyl and Their Combination

NCT04659642 is registered in ClinicalTrials.gov with National Cancer Institute, Egypt as lead sponsor.

NCT NCT04659642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04659642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Attenuation of Airway and Cardiovascular Responses to Extubation in Chronic Smokers by Prior Treatment With Dexmedetomidine, Fentanyl and Their Combination
Lead sponsor
National Cancer Institute, Egypt
Phase
Phase 1
Overall status
Unknown status
Start date
November 30, 2020
Completion date
March 20, 2021
Enrollment
66 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

airway responses, hemodynamic